1. Synthesis, chemical stability and pre-clinical anti-tumor activity of pyrazine diazohydroxide, sodium salt (NSC-361456);Baker;Anticancer Drug Des,1987
2. Pyrazine diazohydroxide (PZDH) NSC 361456. National Cancer Institute Clinical Brochure,1989
3. Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivo;Harrison;Cancer Chemother Pharmacol,1990
4. Experimental chemotherapy studies of a human melanoma in athymic mice using a survival endpoint;Shoemaker;Proc Am Assoc Cancer Res,1985
5. Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer;Vogelzang;Clin Cancer Res,1998